Further supporting a possible role of cytochrome-c as a biomarker, it was shown that cytochrome-c levels were increased in patients with severe encephalopathy (115) as well as in patients on hemodialysis (116) and correlated, respectively, with patient’s outcome and IL-6 levels. This evidence concerns the gene CYCS and Encephalopathy.